Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CatalentPharma
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CatalentPharma
-
In this poster Catalent
#Biologics experts share an example of how a high-throughput preformulation approach was implemented in order to enable a shorter time and less labor-intensive screening for a broad range of conditions. Download here:http://ow.ly/Xdg050yeAu6Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Catalent laying out $315M to snatch another gene therapy
#CDMO https://www.fiercepharma.com/manufacturing/catalent-laying-out-315m-to-snatch-another-gene-therapy-cdmo …https://lnkd.in/ejeJyVzHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Catalent and Natural Products Expo West March 3-7 in Aneheim California. Visit us at booth 4183 and schedule a meeting with our experts.http://ow.ly/DfDf50ydEmL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Catalent Pharma proslijedio/la je Tweet
Did you know? The CRS Corporate Membership Founding Members are meeting at CRS HQ in New Jersey this month. As newly appointed members of the Industry Foresight Council, they will submit an agenda to the CRS Board of Directors & meet for lunch and in-depth discussions.pic.twitter.com/R0rxJba8jo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hear from experts as they share insights into the key processes in formulation, analytical and mfg activities for
#oralsolids,#sterile and#biologics products and discuss key considerations for transitioning#smallmolecules and biologics into the clinic. http://ow.ly/qes150xXQ7J pic.twitter.com/9FpucJhLpJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Catalent Pharma proslijedio/la je Tweet
#acquisition#Blog#pharmaceuticals With the acquisition of@MaSTherCell ,@CatalentPharma spreads its#WINGS into the cell and gene#therapy market. Detailed insight on this emerging trend in cell and gene therapy market is available onhttps://www.rootsanalysis.com/blog/2020/02/04/catalents-shopping-list-hinting-towards-a-one-stop-cell-gene-therapy-cmo-in-making/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hosted in partnership with
@OneNucleus, this workshop will show how a comprehensive end-to-end#biologics solution has the potential to provide higher quality and improved yield of#biopharmaceuticals with reduced cost and time. Attend this free event:http://ow.ly/xh5o50y6MY9Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Catalent to buy Orgenesis’ cell therapy CDMO biz for $315m
@BioProcessIntlhttps://bioprocessintl.com/bioprocess-insider/deal-making/catalent-to-buy-orgenesis-cell-therapy-cdmo-biz-for-315m/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Catalent Chairman and CEO John Chiminski triggers a $315M-plus wager on the booming cell therapy market now in the making. Read the full interview: https://endpts.com/catalent-chief-john-chiminski-triggers-a-315m-plus-wager-on-the-booming-cell-therapy-market-now-in-the-making/ …
#celltherapy#biotech#acquisitionpic.twitter.com/gV3dL4B1zk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform Read more: http://ow.ly/jawX50ybOMV
#pressrelease#celltherapypic.twitter.com/BfpOGHkxz3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Catalent and
@Evonik Industries on March 12 for an interactive workshop on hot melt extrusion. Register today for this complimentary event held at Catalent’s#Somerset, NJ headquarters. http://ow.ly/grJ950y89Xy#Hotmeltextrusion#controlledreleaseHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Discover strategies for selecting suitable formulation techniques for poorly soluble drugs, and learn about recent advances in screening and modelling for predicting solubility. Download today.http://ow.ly/BycQ50y9tGe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Download this on demand
#webinar and hear Catalent's Greg Bleck discuss GPEx® Boost cell line development technology and how it can improve#COGS through higher titers and specific productivities, Download today:#cellline#GPEX#celllinedevelopmenthttp://ow.ly/xJF950xMOe0Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
There is a growing need for streamlining import and export strategies and
#clinicalsupply support in the APAC region. Register for this#webcast to get expert insights on using Singapore as a clinical supply hub. http://ow.ly/9Hyy50y8u6G pic.twitter.com/elNCqjbWYR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Catalent and
@Evonik Industries on March 12 for an interactive workshop on hot melt extrusion. Register today for this complimentary event held at Catalent’s#Somerset, NJ headquarters. http://ow.ly/grJ950y89Xy#Hotmeltextrusion#controlledreleaseHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Catalent is pleased to announce the appointment of Ricci Whitlow as President, Clinical Supply Services. Read the press release:http://ow.ly/N6Qt50y7Z5S
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Polysorbate-80 (PS-80) is a surfactant commonly used as an excipient to improve API stability. This case study describes how to quantitate and characterize
#PS80.#Polysorbate80#surfactant Learn more and download here:http://ow.ly/nlpd50xWvhXHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Catalent at
#WCBP2020 in Washington, D.C. and hear Chris Hepler discuss Conversion of a potency assay from cell-based binding to#AlphaLISA. Visit us at stand 18, January 28-30. Schedule a meeting with our experts today.#WCBP http://ow.ly/5rJc50xTXiW pic.twitter.com/n8A0RlBjh5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Final hours to Register for this
#webinar to hear experts walk through solutions that address the challenges in pediatric drug development that have the potential to improve patient outcomes. Register Today.#drugdevelopment#clinicaltrial#pediatrichttp://ow.ly/Jd2950xQbeGHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn how Catalent tests therapeutic antibodies to ensure stability, safety and efficacy in this scientific poster that explores Multidimensioal evaluation of mAb degradation. Download it today!http://ow.ly/fi4150y5LCD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.